Canine pre-iridal fibrovascular membranes: Morphologic and immunohistochemical investigations

Veterinary Ophthalmology

Volumn 13, Issue 1, 2010, Pages 4-13

  Zarfoss, Mitzi K ^a   Breaux, Carrie B ^b   Whiteley, Herbert E ^a   Hamor, Ralph E ^a   Flaws, Jodi A ^a   Labelle, Philippe ^c   Dubielzig, Richard R ^d  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b WestVet Emergency & Specialty Center   (United States)

^c ANTECH DIAGNOSTICS   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Angiogenesis; Canine; Eye; Immunohistochemistry; Inflammation; Iris

Indexed keywords

CD31 ANTIGEN; COLORING AGENT; CYCLOOXYGENASE 2; VASCULOTROPIN A;

ADENOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; CHEMISTRY; DOG; DOG DISEASE; HISTOLOGY; IMMUNOLOGY; IRIS; IRIS TUMOR; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RETINA DETACHMENT; UVEITIS; VASCULARIZATION;

ADENOMA; ANIMALS; ANTIGENS, CD31; COLORING AGENTS; CYCLOOXYGENASE 2; DOG DISEASES; DOGS; IRIS; IRIS NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RETINAL DETACHMENT; UVEITIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

CANIS FAMILIARIS;

EID: 74549175902     PISSN: 14635216     EISSN: 14635224     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2009.00739.x     Document Type: Article

References (84)

1. Peiffer RL, Jr., Wilcock BP, Yin H. The pathogenesis and significance of pre-iridal fibrovascular membrane in domestic animals. Veterinary Pathology 1990 27 : 41 45.
2. Dubielzig RR, Steinberg H, Garvin H et al. Iridociliary epithelial tumors in 100 dogs and 17 cats: a morphological study. Veterinary Ophthalmology 1998 1 : 223 231.
3. Wilcock BP, Peiffer RL, Jr. The pathology of lens-induced uveitis in dogs. Veterinary Pathology 1987 24 : 549 553.
4. van der Woerdt A. Lens-induced uveitis. Veterinary Ophthalmology 2000 3 : 227 234.
5. Gartner S, Henkind P. Neovascularization of the iris (rubeosis iridis). Survey of Ophthalmology 1978 22 : 291 312.
6. Moore DL, McLellan GJ, Dubielzig RR. A study of the morphology of canine eyes enucleated or eviscerated due to complications following phacoemulsification. Veterinary Ophthalmology 2003 6 : 219 226.
7. Tsai JC, Shields MB. Neovascular glaucoma. In : Ocular Angiogenesis: Diseases, Mechanisms, and Therapeutics eds Tombran-Tink J, Barnstable CJ) Humana Press, Totowa, NJ, 2006 127 147.
8. Adamis AP, Shima DT, Tolentino MJ et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Archives of Ophthalmology 1996 114 : 66 71.
9. Campochiaro PA, Hackett SF. Ocular neovascularization: a valuable model system. Oncogene 2003 22 : 6537 6548.
10. Casey R, Li WW. Factors controlling ocular angiogenesis. American Journal of Ophthalmology 1997 124 : 521 529.
11. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 2004 25 : 581 611. (Pubitemid 39099316)
12. Lutty GA, McLeod DS, Merges C et al. Localization of vascular endothelial growth factor in human retina and choroid. Archives of Ophthalmology 1996 114 : 971 977. (Pubitemid 26271463)
13. Malecaze F, Clamens S, Simorre-Pinatel V et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Archives of Ophthalmology 1994 112 : 1476 1482.
14. Miller JW. Vascular endothelial growth factor and ocular neovascularization. American Journal of Pathology 1997 151 : 13 23.
15. Tolentino MJ, Miller JW, Gragoudas ES et al. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Archives of Ophthalmology 1996 114 : 964 970.
16. Tamura M, Sebastian S, Gurates B et al. Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells. Journal of Clinical Endocrinology and Metabolism 2002 87 : 3504 3507.
17. Takahashi K, Saishin Y, Saishin Y et al. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment. FASEB Journal 2003 17 : 896 898.
18. Yoshida M, Takeuchi M, Streilein JW. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact. Investigative Ophthalmology and Visual Science 2000 41 : 811 821. (Pubitemid 30158893)
19. Samuelson DA. Ophthalmic anatomy. In : Veterinary Ophthalmology ed. Gelatt KN) Blackwell Publishing, Ames, 2007 37 148.
20. Henkind P. Ocular neovascularization. The Krill memorial lecture. American Journal of Ophthalmology 1978 85 : 287 301.
21. Schulze RR. Rubeosis iridis. American Journal of Ophthalmology 1967 63 : 487 495.
22. Parums DV, Cordell JL, Micklem K et al. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. Journal of Clinical Pathology 1990 43 : 752 757.
23. Alam CA, Colville-Nash P, Seed MP. Modeling angiogenesis in inflammation. In : Angiogenesis in Inflammation: Mechanisms and Clinical Correlates eds Seed MP, Walsh DA) Birkhauser Verlag, Basel, Switzerland, 2008 99 148.
24. Lossinsky AS, Wisniewski HM. Immunoultrastructural expression of ICAM-1 and PECAM-1 occurs prior to structural maturity of the murine blood-brain barrier. Developmental Neuroscience 1998 20 : 518 524.
25. Sheibani N, Newman PJ, Frazier WA. Thrombospondin-1, a natural inhibitor of angiogenesis, regulates platelet-endothelial cell adhesion molecule-1 expression and endothelial cell morphogenesis. Molecular Biology of the Cell 1997 8 : 1329 1341.
26. Jerdan JA, Michels RG, Glaser BM. Extracellular matrix of newly forming vessels - an immunohistochemical study. Microvascular Research 1991 42 : 255 265.
27. Hosoda Y, Okada M, Matsumura M et al. Intravitreal neovascular tissue of proliferative diabetic retinopathy: an immunohistochemical study. Ophthalmic Research 1992 24 : 260 264.
28. Wallow IH, Stevens TS, Greaser ML et al. Actin filaments in contracting preretinal membranes. Archives of Ophthalmology 1984 102 : 1370 1375.
29. Abu El-Asrar AM, Van den Steen PE, Al-Amro SA et al. Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders. International Ophthalmology 2007 27 : 11 22.
30. Naranjo C, Dubielzig RR. A Syndrome of Intravitreal Glial Aggregates, Intravitreal Neovascular Proliferation, Neovascular Glaucoma and Intraocular Hemorrhage in 21 Dogs. American College of Veterinary Ophthalmology Conference, San Antonio, TX, 2006.
31. Bradbury P, Gordon KC. Connective tissues and stains. In : Theory and Practice of Histological Techniques eds Bancroft JD, Stevens A) Churchill Livingstone, Edinburgh, 1982 122 144.
32. Cook HC. Carbohydrates. In : Theory and Practice of Histological Techniques eds Bancroft JD, Stevens A) Churchill Livingstone, Edinburgh, 1982 122 144.
33. Hinz B, Dugina V, Ballestrem C et al. Alpha-smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. Molecular Biology of the Cell 2003 14 : 2508 2519.
34. Woodley DT, Stanley JR, Reese MJ et al. Human dermal fibroblasts synthesize laminin. Journal of Investigative Dermatology 1988 90 : 679 683.
35. Soini Y, Autio-Harmainen H, Miettinen M. Immunoreactivity for laminin and type IV collagen in malignant and benign fibrous histiocytoma. Journal of Pathology 1989 158 : 223 228.
36. Berndt A, Kosmehl H, Katenkamp D et al. Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix. Pathobiology 1994 62 : 55 58.
37. de Iongh RU, Wederell E, Lovicu FJ et al. Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation. Cells Tissues Organs 2005 179 : 43 55.
38. Jester JV, Petroll WM, Cavanagh HD. Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Progress in Retinal and Eye Research 1999 18 : 311 356.
39. Roscoe WA, Welsh ME, Carter DE et al. VEGF and angiogenesis in acute and chronic MOG(35-55) peptide induced EAE. Journal of Neuroimmunology 2009 209 : 6 15.
40. John T, Sassani JW, Eagle RC, Jr. Scanning electron microscopy of rubeosis iridis. Transactions-Pennsylvania Academy of Ophthalmology and Otolaryngology 1982 35 : 119 121.
41. Karamysheva AF. Mechanisms of angiogenesis. Biochemistry (Moscow) 2008 73 : 751 762.
42. Marshall JL, Stanfield KM, Silverman L et al. Enhanced expression of cyclooxygenase-2 in glaucomatous dog eyes. Veterinary Ophthalmology 2004 7 : 59 62.
43. Maatta M, Heljasvaara R, Pihlajaniemi T et al. Collagen XVIII/endostatin shows a ubiquitous distribution in human ocular tissues and endostatin- containing fragments accumulate in ocular fluid samples. Graefes Archive for Clinical and Experimental Ophthalmology 2007 245 : 74 81.
44. Stitt AW, Simpson DA, Boocock C et al. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours. Journal of Pathology 1998 186 : 306 312.
45. Chen Z, Jia W, Kaufman PL et al. Immunohistochemical localization of dopamine-beta-hydroxylase in human and monkey eyes. Current Eye Research 1999 18 : 39 48.
46. Bakker M, Kijlstra A. The expression of HLA-antigens in the human anterior uvea. Current Eye Research 1985 4 : 599 604.
47. Nork TM, Tso MO, Duvall J et al. Cellular mechanisms of iris neovascularization secondary to retinal vein occlusion. Archives of Ophthalmology 1989 107 : 581 586.
48. Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell and Tissue Research 2003 314 : 15 23.
49. Frid MG, Kale VA, Stenmark KR. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circulation Research 2002 90 : 1189 1196.
50. Witmer AN, van Blijswijk BC, van Noorden CJ et al. In vivo angiogenic phenotype of endothelial cells and pericytes induced by vascular endothelial growth factor-A. Journal of Histochemistry and Cytochemistry 2004 52 : 39 52.
51. Auguste P, Vincent F, Gabbiani G et al. The fibroblast and myofibroblast in inflammatory angiogenesis. In : Angiogenesis in Inflammation: Mechanisms and Clinical Correlates eds Seed MP, Walsh DA) Springer, Basel, 2008 59 82.
52. Saint-Geniez M, Maharaj AS, Walshe TE et al. Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. PLoS ONE 2008 3 : e3554.
53. Kim I, Ryan AM, Rohan R et al. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. Investigative Ophthalmology and Visual Science 1999 40 : 2115 2121.
54. Castro MR, Lutz D, Edelman JL. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization. Experimental Eye Research 2004 79 : 275 285.
55. Campochiaro PA. Ocular versus extraocular neovascularization: mirror images or vague resemblances. Investigative Ophthalmology and Visual Science 2006 47 : 462 474.
56. Taylor PC. The angiogenic drive in chronic inflammation: hypoxia and the cytokine milieu. In : Angiogenesis in Inflammation: Mechanisms and Clinical Correlates eds Seed MP, Walsh DA) Birkhauser Verlag, Basel, Switzerland, 2008 15 28.
57. Philipp W, Speicher L, Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Investigative Ophthalmology and Visual Science 2000 41 : 2514 2522.
58. Matsuoka M, Ogata N, Minamino K et al. Expression of pigment epithelium-derived factor and vascular endothelial growth factor in fibrovascular membranes from patients with proliferative diabetic retinopathy. Japanese Journal of Ophthalmology 2006 50 : 116 120.
59. Sellers RS, Silverman L, Khan KN. Cyclooxygenase-2 expression in the cornea of dogs with keratitis. Veterinary Pathology 2004 41 : 116 121.
60. Kulkarni PS, Fleisher L, Srinivasan BD. The synthesis of cyclooxygenase products in ocular tissues of various species. Current Eye Research 1984 3 : 447 452.
61. Amico C, Yakimov M, Catania MV et al. Differential expression of cyclooxygenase-1 and cyclooxygenase-2 in the cornea during wound healing. Tissue and Cell 2004 36 : 1 12.
62. Zidar N, Odar K, Glavac D et al. Cyclooxygenase in normal human tissues - is COX-1 really a constitutive isoform, and COX-2 an inducible isoform? Journal of Cellular and Molecular Medicine 2008. Postprint: 10.1111/j.1582-4934.2008. 00430.x.
63. Chiang CC, Cheng YW, Lin CL et al. Cyclooxygenase 2 expression in pterygium. Molecular Vision 2007 13 : 635 638.
64. Radi ZA, Render JA. The pathophysiologic role of cyclo-oxygenases in the eye. Journal of Ocular Pharmacology and Therapeutics 2008 24 : 141 151.
65. Karahan N, Baspinar S, Ciris M et al. Cyclooxygenase-2 expression in primary and recurrent pterygium. Indian Journal of Ophthalmology 2008 56 : 279 283.
66. Wang W, Bergh A, Damber JE. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer. Clinical Cancer Research 2005 11 : 3250 3256.
67. Yucel-Lindberg T, Brunius G, Wondimu B et al. Enhanced cyclooxygenase-2 mRNA expression in human gingival fibroblasts induced by cell contact with human lymphocytes. European Journal of Oral Sciences 2001 109 : 187 192.
68. Rocca B, FitzGerald GA. Cyclooxygenases and prostaglandins: shaping up the immune response. International Immunopharmacology 2002 2 : 603 630.
69. Feldon SE, O'Loughlin CW, Ray DM et al. Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. American Journal of Pathology 2006 169 : 1183 1193.
70. Cope AP. Studies of T-cell activation in chronic inflammation. Arthritis Research 2002 4 (Suppl 3 S197 S211.
71. Tatar O, Shinoda K, Adam A et al. Expression of endostatin in human choroidal neovascular membranes secondary to age-related macular degeneration. Experimental Eye Research 2006 83 : 329 338.
72. Sahin A, Kiratli H, Tezel GG et al. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas. Ophthalmic Research 2007 39 : 40 44.
73. Tse GM, Lui PC, Lee CS et al. Stromal expression of vascular endothelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases. Human Pathology 2004 35 : 1053 1057.
74. Heller DA, Fan TM, de Lorimier LP et al. In vitro cyclooxygenase-2 protein expression and enzymatic activity in neoplastic cells. Journal of Veterinary Internal Medicine 2007 21 : 1048 1055.
75. Bussolati G, Leonardo E. Technical pitfalls potentially affecting diagnoses in immunohistochemistry. Journal of Clinical Pathology 2008 61 : 1184 1192.
76. Bradley J, Ju M, Robinson GS. Combination therapy for the treatment of ocular neovascularization. Angiogenesis 2007 10 : 141 148.
77. Campochiaro PA. Gene therapy for ocular neovascularization. Current Gene Therapy 2007 7 : 25 33.
78. Clark AF. Mechanism of action of the angiostatic cortisene anecortave acetate. Survey of Ophthalmology 2007 52 (Suppl 1 S26 S34.
79. Avery RL. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 2006 26 : 352 354.
80. Takahashi K, Saishin Y, Saishin Y et al. Topical nepafenac inhibits ocular neovascularization. Investigative Ophthalmology and Visual Science 2003 44 : 409 415.
81. Paroli MP, Teodori C, D'Alessandro M et al. Increased vascular endothelial growth factor levels in aqueous humor and serum of patients with quiescent uveitis. European Journal of Ophthalmology 2007 17 : 938 942.
82. Szekanecz Z, Koch AE. Chemokines and cytokines in inflammatory angiogenesis. In : Angiogenesis in Inflammation: Mechanisms and Clinical Correlates eds Seed MP, Walsh DA) Birkhauser Verlag, Basel, Switzerland, 2008 83 98.
83. Pearce JW, Janardhan KS, Caldwell S et al. Angiostatin and integrin alphavbeta3 in the feline, bovine, canine, equine, porcine and murine retina and cornea. Veterinary Ophthalmology 2007 10 : 313 319.
84. Memarzadeh F, Li Y, Francis BA et al. Optical coherence tomography of the anterior segment in secondary glaucoma with corneal opacity after penetrating keratoplasty. British Journal of Ophthalmology 2007 91 : 189 192.